Format

Send to

Choose Destination
  • The following term was not found in PubMed: Jan;96.
  • Quoted phrase not found.
Br J Ophthalmol. 2012 Jan;96(1):3-9. doi: 10.1136/bjo.2011.204701. Epub 2011 Jun 28.

Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable.

Author information

1
Department of Ophthalmology, University of Cologne, Joseph-Stelzmann Strasse 9. 50924, Cologne, Germany. claus.cursiefen@uk-koeln.de

Abstract

The cornea is the clear window at the front of the eye and is the eye's main refractive medium. Its transparency is essential for vision. Corneal neovascularisation is a common clinical problem with serious consequences for vision; it can compromise corneal transparency and plays a major role in corneal graft rejection by breaching corneal immune privilege. In this review, we formulate a consensus on the unmet medical needs in the management of corneal neovascularisation and outline a framework for the clinical research that is needed to identify suitable agents to meet these needs.

PMID:
21712359
DOI:
10.1136/bjo.2011.204701
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center